(TRC, North York, Canada)
BMI is measured at the time GLP-1 therapy is initiated not at the time of the prior authorization submission
CoA-LOT: BN260122/CA
thus liraglutide and oral semaglutide significantly reduced cardiovascular death, subcutaneous semaglutide and dulaglutide significantly reduced nonfatal stroke, albiglutide reduced the risk of nonfatal myocardial infarction, and epfeglenatide reduced the incidence of heart failure, while weekly exenatide or lixisenatide showed no significant benefit on any component of MACE
FAST FACTS Benefit/s: For immunity, For the bladder, For bones & joints, For the brain, Energy boost, Fertilily & pregnancy support, For the heart, Hormone management, For the respiratory system, Stress & sleep aid, Multivitamins, Beauty supplement, For the skin
However, everyone's health journey is unique